OMER
NASDAQ
US
Omeros Corporation - Common Stock
$10.90
▼ $-1.18
(-9.77%)
Vol 1.8M
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.2B
ROE
107.5%
Margin
-202.0%
D/E
2154.86
Beta
2.58
52W
$3–$18
Wall Street Consensus
11 analysts · Apr 20263
Strong Buy
5
Buy
3
Hold
0
Sell
0
Strong Sell
72.7%
Buy Rating
Price Chart
Similar Stocks
AMPH
Amphastar Pharmaceuticals Inc
P/E 11.0
$1.2B
PCRX
Pacira Biosciences Inc
P/E 51.9
$1.1B
PHAT
Phathom Pharmaceuticals Inc
$1.2B
BIOA
BIOAGE Labs Inc
$474.4M
SGP
SpyGlass Pharma Inc
RLMD
Relmada Therapeutics Inc
$354.2M
ARVN
Arvinas Inc
$761.7M
ETON
Eton Pharmaceuticals Inc
$453.5M
LXRX
Lexicon Pharmaceuticals Inc
$417.9M
Earnings
Beat rate: 60.0%
Next Report
May 13, 2026
EPS Estimate: $-0.46
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.46 | — | — |
| Dec 2025 | $-0.58 | $0.98 | +$1.56 |
| Sep 2025 | $-0.45 | $-0.47 | $-0.02 |
| Jun 2025 | $-0.49 | $-0.43 | +$0.06 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | 107.5% | 107.5% | 107.5% | 107.5% | 107.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -202.0% | -202.0% | -202.0% | -202.0% | -202.0% |
| Gross Margin | — | 98.8% | 98.8% | 98.8% | 98.8% | 98.8% |
| D/E Ratio | — | 2154.86 | 2154.86 | 2154.86 | 2154.86 | 2154.86 |
| Current Ratio | 0.81 | 0.81 | 0.81 | 0.81 | 0.89 | 0.89 |
Key Ratios
ROA (TTM)
-53.9%
P/S (TTM)
17.07
P/B
1.7
EPS (TTM)
$-2.02
CF/Share
$-2.88
52W High
$17.65
52W Low
$2.95
$2.95
52-Week Range
$17.65
How does OMER compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
OMER valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
17.1
▲
245%
above
peers
(5.0)
vs Peers
vs Industry
Pricier
P/B ratio
1.7
▼
22%
below
peers
(2.1)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
OMER profitability vs Pharmaceuticals peers
ROE
107.5%
▲
298%
above
peers
(-54.3%)
vs Peers
vs Industry
Top tier
Net margin
-202.0%
▼
326%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
98.8%
▲
45%
above
peers
(68.3%)
vs Peers
vs Industry
Below avg
ROA
-53.9%
▼
44%
below
peers
(-37.4%)
vs Peers
vs Industry
Below avg
OMER financial health vs Pharmaceuticals peers
D/E ratio
2154.9
▲
139826%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
0.9
▼
74%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
2.6
▲
175%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
OMER fundamentals radar
OMER
Peer median
Industry
OMER profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
OMER vs peers: key metrics
Latest News
Lloyds bank faces £66m court battle with car loan customers
The Guardian · Mar 27
Utility Entergy says revised Meta data-center deal to deliver higher customer savings
Yahoo Finance · Mar 27
Lloyds bank reveals IT glitch affected almost half a million customers
BBC Business · Mar 27
OpenAI Just Became Broadcom's Newest Chip Customer. Here's Why That's a Massive …
Nasdaq · Mar 26
DraftKings (DKNG) Investing to Revitalize Growth Amid Competition and Customer Acquisition Concerns
Yahoo Finance · Mar 25